Alliance for Clinical Trials in Oncology

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 2011-01-01

Employees: 251

Market Cap: -

Website: https://www.allianceforclinicaltrialsinoncology.org

Clinical Trials

Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy

Phase 3

Completed

Conditions: Chronic Myeloproliferative Disorders
Anemia
Drug/Agent Toxicity by Tissue/Organ
Leukemia
Multiple Myeloma and Plasma Cell Neoplasm
Unspecified Adult Solid Tumor, Protocol Specific
Small Intestine Cancer
Breast Cancer
Lung Cancer
Lymphoma

Interventions: Other: placebo
Biological: epoetin alfa

First Posted Date: 2004-02-20

Last Posted Date: 2016-07-13

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 344

Registration Number: NCT00003600

Locations: 🇺🇸
Howard University Cancer Center, Washington, District of Columbia, United States
🇺🇸
CCOP - Illinois Oncology Research Association, Peoria, Illinois, United States
🇺🇸
CCOP - Carle Cancer Center, Urbana, Illinois, United States

and more 18 locations

High-Dose Multivitamins Compared to a Placebo in Preventing the Recurrence of Cancer in Patients With Early Stage Bladder Cancer

Phase 3

Completed

Conditions: Bladder Cancer

Interventions: Other: Placebo
Dietary Supplement: multivitamin

First Posted Date: 2004-02-20

Last Posted Date: 2016-07-13

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 21

Registration Number: NCT00003623

Locations: 🇺🇸
CCOP - Cedar Rapids Oncology Project, Cedar Rapids, Iowa, United States
🇺🇸
CCOP - Wichita, Wichita, Kansas, United States
🇺🇸
CCOP - Toledo Community Hospital Oncology Program, Toledo, Ohio, United States

and more 14 locations

Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are Undergoing Lung Resection for Suspicious Stage I Lung Lesions

Completed

Conditions: Lung Cancer

Interventions: Genetic: proteomic profiling
Other: surface-enhanced laser desorption/ionization-time of flight mass spectrometry
Procedure: biopsy
Procedure: surgery

First Posted Date: 2004-02-12

Last Posted Date: 2016-07-06

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 1000

Registration Number: NCT00077324

Locations: 🇺🇸
Western Pennsylvania Cancer Institute at Western Pennsylvania Hospital, Pittsburgh, Pennsylvania, United States
🇺🇸
Fox Chase Cancer Center - Philadelphia, Philadelphia, Pennsylvania, United States
🇺🇸
Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States

and more 70 locations

Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Phase 2

Completed

Conditions: Anemia
Drug/Agent Toxicity by Tissue/Organ
Lung Cancer
Neutropenia

Interventions: Biological: darbepoetin alfa
Biological: pegfilgrastim
Drug: cisplatin
Drug: docetaxel
Drug: BNP7787

First Posted Date: 2004-02-12

Last Posted Date: 2016-06-30

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 160

Registration Number: NCT00077311

Locations: 🇺🇸
Graham Hospital, Canton, Illinois, United States
🇺🇸
Greenebaum Cancer Center at University of Maryland Medical Center, Baltimore, Maryland, United States
🇺🇸
Veterans Affairs Medical Center - Baltimore, Baltimore, Maryland, United States

and more 61 locations

Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung

Phase 2

Completed

Conditions: Metastatic Cancer
Melanoma (Skin)

Interventions: Biological: sargramostim

First Posted Date: 2004-02-12

Last Posted Date: 2016-07-13

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 28

Registration Number: NCT00005610

Locations: 🇺🇸
CCOP - Carle Cancer Center, Urbana, Illinois, United States
🇺🇸
CCOP - Duluth, Duluth, Minnesota, United States
🇺🇸
CentraCare Clinic, Saint Cloud, Minnesota, United States

and more 15 locations

FOLFIRI or FOLFOX With or Without Cetuximab in Patients With Metastatic Adenocarcinoma of the Colon or Rectum

Phase 3

Terminated

Conditions: Colorectal Cancer

Interventions: Drug: 5-FU
Drug: cetuximab
Drug: irinotecan
Drug: leucovorin
Drug: oxaliplatin

First Posted Date: 2004-02-11

Last Posted Date: 2018-05-16

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 238

Registration Number: NCT00077233

Locations: 🇺🇸
Memorial Regional Cancer Center at Memorial Regional Hospital, Hollywood, Florida, United States
🇺🇸
MBCCOP - University of Illinois at Chicago, Chicago, Illinois, United States
🇺🇸
CCOP - Northern Indiana CR Consortium, South Bend, Indiana, United States

and more 74 locations

Comparison of Nicotine Inhaler and/or Bupropion in Helping People to Stop Smoking and Prevent the Recurrence of Smoking

Phase 3

Completed

Conditions: Lung Cancer

Interventions: Drug: bupropion hydrochloride
Drug: nicotine
Other: placebo

First Posted Date: 2004-02-06

Last Posted Date: 2016-07-13

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 1708

Registration Number: NCT00033592

Locations: 🇺🇸
Cancer Center of Kansas - Wichita, Wichita, Kansas, United States
🇺🇸
CCOP - Carle Cancer Center, Urbana, Illinois, United States
🇺🇸
CCOP - Scottsdale Oncology Program, Scottsdale, Arizona, United States

and more 22 locations

Vinorelbine in Treating Older Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

Phase 2

Completed

Conditions: Lung Cancer

Interventions: Drug: vinorelbine tartrate

First Posted Date: 2004-02-03

Last Posted Date: 2016-07-13

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 59

Registration Number: NCT00008333

Locations: 🇺🇸
Siouxland Hematology-Oncology, Sioux City, Iowa, United States
🇺🇸
CCOP - Geisinger Clinic and Medical Center, Danville, Pennsylvania, United States
🇺🇸
CCOP - Cedar Rapids Oncology Project, Cedar Rapids, Iowa, United States

and more 10 locations

506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver Impairment

Phase 1

Terminated

Conditions: Chronic Myeloproliferative Disorders
Leukemia
Lymphoma
Multiple Myeloma and Plasma Cell Neoplasm
Myelodysplastic Syndromes

Interventions: Drug: Compound 506U78

First Posted Date: 2004-01-29

Last Posted Date: 2016-07-04

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 10

Registration Number: NCT00004239

Locations: 🇺🇸
Comprehensive Cancer Center at Wake Forest University, Winston-Salem, North Carolina, United States
🇺🇸
Holden Comprehensive Cancer Center at The University of Iowa, Iowa City, Iowa, United States
🇺🇸
University of Chicago Cancer Research Center, Chicago, Illinois, United States

Irinotecan in Treating Patients With Advanced Cancer of the Stomach

Phase 2

Completed

Conditions: Gastric Cancer
Esophageal Cancer

Interventions: Drug: irinotecan hydrochloride

First Posted Date: 2004-01-22

Last Posted Date: 2016-07-14

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 70

Registration Number: NCT00003137

Locations: 🇺🇸
Mayo Clinic Jacksonville, Jacksonville, Florida, United States
🇺🇸
CCOP - Cedar Rapids Oncology Project, Cedar Rapids, Iowa, United States
🇺🇸
CCOP - Illinois Oncology Research Association, Peoria, Illinois, United States

and more 16 locations

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy